跳至主要内容
临床试验/NCT01272323
NCT01272323已完成不适用

An Optional 1 Year Follow up Study to Evaluate the Continued Efficacy of Cat-PAD in Cat Allergic Subjects Following Challenge to Cat Allergen in an Environmental Exposure Chamber

Circassia Limited1 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
170
试验地点
1
主要终点
Total Rhinoconjunctivitis Symptom Score

研究概览

简要总结

Cat allergy is an increasingly prevalent condition, affecting 10-15% of patients with allergic rhinoconjunctivitis and/or asthma.

The purpose of this optional observational follow-on study is to further evaluate rhinoconjunctivitis symptoms on exposure to cat dander in the EEC among subjects who completed all dosing visits in study CP005 approximately one year after the start of treatment.

详细描述

Subjects who completed all dosing visits and the post treatment challenge (PTC) in study CP005 will be invited to attend the Screening Visit for CP005A. Subjects will attend for 4 visits to the EEC on successive days. Following the last EEC visit a follow-up visit will be performed 3-10 days later.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Total Rhinoconjunctivitis Symptom Score

时间窗: 50-54 weeks after the start of treatment in CP005

次要结局

  • Total Symptom scores for ocular and nasal symptoms(50-54 weeks after the start of treatment in CP005)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验